Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Neuropathic Pruritus, Iron Deficiency, and Dopamine in Pruritic Conditions Including Atopic Dermatitis, Prurigo Nodularis, and Delusions of Parasitosis
Description
Jesse Keller, a dermatologist with expertise in psychodermatology, discusses the complexities of neuropathic pruritus and its connections to conditions like atopic dermatitis and delusions of parasitosis. He emphasizes the role of biological mechanisms behind itch, specifically differentiating between neuropathic and inflammatory causes. Keller notes that neuropathic pruritus often presents with disproportionate itch without primary skin findings, sometimes accompanied by psychiatric backgrounds. He explains the neurobiological interplay involving neuropeptides like substance P and calcitonin gene-related peptide that contribute to itch sensation, while also considering the impact of dopamine dysregulation and iron deficiency. He highlights how chronic stress can affect immune responses and itch perception. Keller presents treatment options, including medications aimed at balancing dopamine levels and managing itch, such as pregabalin and antipsychotics like pimozide. He also mentions promising new therapies targeting cytokines related to pruritic conditions. Keller's research includes exploring the role of iron deficiency linked to delusions of parasitosis and the neurobiological underpinnings of formication. He concludes by sharing a case study of a patient with delusional infestation who improved with dupilumab, underscoring the significance of identifying eosinophilia in guiding treatment approaches.
View moreConclusions
- Neuropathic pruritus often presents with an itch intensity out of proportion to physical findings, suggesting a complex interplay of physical and psychological factors.
- Chronic psychosocial stress can exacerbate itch through neuroinflammatory mechanisms, impacting cytokine levels and nerve signaling.
- Iron deficiency is a prevalent condition among patients with delusions of parasitosis and may contribute significantly to neuropathic pruritus and formication.
- Antipsychotics provide a dual benefit by inhibiting dopamine signaling and modulating inflammatory pathways, potentially aiding in the management of chronic itch.
- New biologics targeting cytokines like oncostatin M and interleukin 31 might offer new treatment strategies for prurigo nodularis and related conditions.
- Formication may reflect a syndrome characterized by both psychological and neurological components, particularly relating to dopamine metabolism and iron levels.
- Early screening for iron deficiency in unexplained pruritic conditions can lead to better targeted therapies and management of chronic itch.
- Medications like pregabalin and naltrexone are effective first-line treatments for various pruritic disorders, including those with an underlying neurologic and psychiatric basis.
- Am J Psychiatry. 2023 Feb 22;appiajp20220737. doi: 10.1176/appi.ajp.20220737. Online ahead of print.
- J Am Acad Dermatol. 2023 Apr 12;S0190-9622(23)00586-8. doi: 10.1016/j.jaad.2023.03.051.
- Exp Dermatol. 2021 Jun;30(6):804-810. doi: 10.1111/exd.14279. Epub 2021 Feb 1.
- Lancet. 1979 Mar 17;1(8116):605. doi: 10.1016/s0140-6736(79)91025-0.
- Blood. 2011 Mar 24;117(12):3421-9. doi: 10.1182/blood-2009-11-255232. Epub 2011 Jan 13.
- Genes Cancer. 2012 Jul;3(7-8):503-11. doi: 10.1177/1947601912466555.
- Int J Oncol. 2016 Jan;48(1):322-8. doi: 10.3892/ijo.2015.3229. Epub 2015 Nov 4.
- Oncotarget. 2018 Oct 9;9(79):34889-34910. doi: 10.18632/oncotarget.26175.